E4orf3 is necessary for enhanced S-phase replication of cell cycle-restricted subgroup C adenoviruses
about
A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibitionAdenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection.E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factorAdenoviral vectors stimulate glucagon transcription in human mesenchymal stem cells expressing pancreatic transcription factors.Adenovirus replaces mitotic checkpoint controls.Biophysical and functional analyses suggest that adenovirus E4-ORF3 protein requires higher-order multimerization to function against promyelocytic leukemia protein nuclear bodiesInactivating intracellular antiviral responses during adenovirus infection.E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirusDiverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background.Oncolytic-adenovirus-expressed RNA interference for cancer therapy.RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection.Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 proteinThe adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.Identifying host factors associated with DNA replicated during virus infection.Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral responseAdenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism.
P2860
Q28477181-E080389B-4A9F-4D0F-807D-1678793F0F6EQ30430013-C2DA8FC7-96B1-4ACB-839D-BC1CDDF7B6A2Q33708518-4C038D06-2891-48A9-95BF-5413B1030BAFQ34460933-F043241C-810B-4022-A064-5936ECB3BFF2Q35488742-DF0191B5-55D8-44EA-8468-7171D8CE2D06Q36080550-9226A2D0-D527-4137-96DE-F4F469487CE3Q36318156-CC5FC2F8-3B71-4D75-A4CF-4C1FA0E02D2EQ37110666-3E216876-E0EA-468F-8428-E7ED1C9872F5Q37492831-7E1BA1EE-B70D-46F7-9D69-5250395FA1F0Q37777745-6FC4B074-C6D9-41A3-9A69-1B2F7DF32E7AQ39858149-304BA553-97D5-459A-B317-C1D5C3666FA1Q39879570-ABE3159F-3C34-40C0-990E-7F0A9524A96FQ39982335-C0B799B0-E369-4208-AE1B-1F0232B64C02Q40173431-1D410540-7732-4DDD-89A3-CF7BB60CE6A5Q41925671-DF0C0153-7760-48B4-8D5D-55B82E49927CQ42040593-4E76F8C6-2E9D-4E1F-BCB1-D220F373FF2DQ42326367-2D99478E-20C7-4AEA-B767-BBA83348BFBC
P2860
E4orf3 is necessary for enhanced S-phase replication of cell cycle-restricted subgroup C adenoviruses
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@ast
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@en
type
label
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@ast
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@en
prefLabel
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@ast
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@en
P2860
P1433
P1476
E4orf3 is necessary for enhanc ...... ricted subgroup C adenoviruses
@en
P2093
David A Ornelles
Robin N Shepard
P2860
P304
P356
10.1128/JVI.77.15.8593-8595.2003
P407
P577
2003-08-01T00:00:00Z